DelveInsight launched its new report on Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030.
DelveInsight’s ‘Hidradenitis Suppurativa (HS) – Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Hidradenitis Suppurativa epidemiology in the 7MM, i.e., the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan.
“The total prevalent population of HidradenitisSuppurativain 7MM was found to be 6,851,308 in 2017.”
Scope of the report:1. The HS report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns2. The HS Report and Model provide an overview of the risk factors and global trends of HS in the seven major markets (7MM: US, Germany, France, Italy, Spain, and the United Kingdom, and Japan)3. The report provides insight into the historical and forecasted patient pool of HS in seven major markets covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom) and Japan4. The report helps to recognize the growth opportunities in the 7MM with respect to the patient population5. The report assesses the disease risk and burden and highlights the unmet needs of HS6. The report provides the segmentation of the HS epidemiology by Age-specific diagnosed prevalent Cases of HS in 7MM7. The report provides the segmentation of the HS epidemiology by Gender-specific diagnosed prevalent Cases of HS in 7MM8. The report provides the segmentation of the HS epidemiology by Stage-Specific diagnosed prevalent Cases of HS in 7MM
Reports highlights:1. 11-Year Forecast of Hidradenitis Suppurativa epidemiology2. 7MM Coverage3. Total Diagnosed prevalent Cases of Hidradenitis Suppurativa4. Diagnosed Prevalent Cases according to segmentation: Gender-specific, Age-specific, Stage-specific Incidence5. Treated cases of Hidradenitis Suppurativa
Table of contents:1. Key Insights2. Executive Summary: Hidradenitis Suppurativa (HS)3. SWOT Analysis: Hidradenitis Suppurativa (HS)4. Hidradenitis Suppurativa (HS) Patient Share (%) Overview at a Glance5. Hidradenitis Suppurativa Market Overview at a Glance6. Disease Overview: Hidradenitis Suppurativa (HS)7. Epidemiology and Patient Population8. Country-wise Epidemiology of HS in the 7MM9. Appendix10. Disclaimer11. DelveInsight Capabilities12. About DelveInsight
Related reports:
Hidradenitis Suppurativa (HS)-Market Insights, Epidemiology and Market Forecast-2030
Hidradenitis – Market Insights, Epidemiology, and Market Forecast-2030
Hidradenitis – Epidemiology Forecast to 2030
Hidradenitis Pipeline Insight, 2020
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Kritika RehaniEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NevadaCountry: United StatesWebsite: https://www.delveinsight.com/